Development

Agnes Shanley is senior editor of Pharmaceutical Technology.

Articles

For successful partnerships, it’s important to take a long-term view, focus on simple designs, and address potential payer concerns up front.

Keeping It Simple: Collaborating for Success in Drug Delivery

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Capacity expansions and new products meet needs for inhaler and injector systems.

Drug-Delivery Market Growth Spurs Expansion and Innovation

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Parenteral drug delivery offers a variety of challenges but also opportunities. The author examines recent developments in nanotechnology-based drug delivery and other advances in injection-based drug delivery.

Delivering Complex Drugs With Nanotechnology-Based Solutions

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Oval Medical Technologies, an autoinjector company based in Cambridge, UK, reported that a variety of highly viscous solutions have been successfully delivered through a 25-gauge thin-wall needle, in less than 7 seconds, using its innovative autoinjector. The technology provides solutions to problems in the industry for drug containment and the end user.

Oval's Innovative Autoinjector Enables Delivery of High-Viscosity Formulations

Engineering nanoparticles with optimal properties for use in cancer therapies.

Nanoparticles: Facilitating Targeted Drug Delivery in Cancer Therapy

The author discusses potential opportunities to improve the patient experience through formulation and delivery device technologies.

Optimizing Drug Delivery for Modern Biologics

Dave Abram is manager of validation and technical services at BioConvergence LLC, 4320 West Zenith Drive, Bloomington, IN 47404, tel. 812.961.1700, fax 812.961.1733.

The author details the factors in formulation design, requirements in facilites and equipment, and validation criteria for aseptic formualtions.

Current Perspectives on Aseptic Formulations

Gert W. Bos is an assistant in business development at OctoPlus BV, Zernikedreef 12, 2333 CL Leiden, The Netherlands.

Two types of hydrogels used in parenteral protein-delivery systems offer opportunities for achieving a variety of prolonged- and delayed-release patterns.

Formulation and Drug Delivery, Parenterals